Supreme Court abortion case could force Trump to take a public stance on mifepristone
The Supreme Court has temporarily held the ruling while the Justice Department and Food and Drug Administration review mifepristone rules for several months.
- On Friday, the U.S. 5th Circuit Court of Appeals ruled to restrict nationwide mifepristone access by requiring in-person doctor visits, upending the Trump administration's strategy of avoiding federal intervention in medication abortion.
- Anti-Abortion advocates have grown increasingly frustrated with the Trump administration's attempt to maintain existing FDA regulations and avoid the abortion debate, arguing the administration should do more to restrict the drug.
- The Supreme Court issued an emergency administrative stay on Monday, restoring telehealth mifepristone access until May 11, with Louisiana asked to file briefs by Thursday, May 7.
- Democrats are seizing on the case, with the Democratic National Committee accusing the Trump administration on Monday of making reproductive healthcare harder to obtain, creating political headwinds for Republicans.
- With medication abortion accounting for 63 percent of U.S. abortions, constitutional law professor Mary Ziegler noted "it's hard to see a scenario where this just goes away as a political issue.
15 Articles
15 Articles
Idaho State Journal
Idaho PressUS Supreme Court issues temporary stay preserving nationwide abortion drug access
The U.S. Supreme Court issued a temporary stay on an appeals court ruling from Friday that was blocking remote access to an abortion drug, restoring access until at least May 11.
Attorney General Raoul: Supreme Court Enters Administrative Stay, Preventing Restrictions On Mifepristone Going Into Effect
CHICAGO – Attorney General Kwame Raoul today announced the U.S. Supreme Court entered an administrative stay to pause a ruling by the U.S. Court of Appeals for the 5th Circuit that would restrict access to mifepristone, a safe and effective abortion medication. The order was entered shortly after Raoul and a coalition of 22 attorneys general and the governor of Pennsylvania filed an amicus brief with the Supreme Court in the case.Raoul and the c…
The Supreme Court may force Trump to take a position on mifepristone
The return of abortion to the Supreme Court is testing President Donald Trump’s strategy of avoiding the issue as the anti-abortion advocates grow increasingly frustrated that his administration hasn’t done more to crack down on access to mifepristone, the drug approved to terminate pregnancies.
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
